Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Osterwalder

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Voprosy Onkologii|September 8, 2000
[A comparative randomized phase-II study of Xeloda (capecitabine) and paclitaxel in patients with breast cancer progressing after anthracycline antibiotics]V M Moiseenko, S M O'Reilly, D C Dalbot, et al.
British Journal of Cancer|June 1, 1995
Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanomaW H Kruit, S H Goey, F Calabresi, et al.
Transplantation|August 1, 1983
Immunologic reactivity in marrow graft recipients receiving cyclosporine to prevent graft-versus-host diseaseV E Von Fliedner, M Jeannet, A Gratwohl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancerM Mackean, A Planting, C Twelves, et al.
Thymus|January 1, 1987
A comparison between ALG and bone marrow transplantation in treatment of severe aplastic anemiaB Speck, A Gratwohl, C Nissen, et al.
British Journal of Cancer|December 1, 1996
Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancerS H Goey, J W Gratama, J N Primrose, et al.
Experimental Hematology|February 1, 1986
Treatment of severe aplastic anemiaB Speck, A Gratwohl, C Nissen, et al.
Schweizerische Medizinische Wochenschrift|November 8, 1986
[Adverse effects of total body irradiation for bone marrow transplantation: prevention and therapy. Experience at Basel, July 1979-March 1986]A Tichelli, A Gratwohl, B Speck, et al.
British Journal of Cancer|July 7, 2000
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumoursL C Pronk, P Vasey, A Sparreboom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patientsB Reigner, J Verweij, L Dirix, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Voprosy Onkologii|September 8, 2000
[A comparative randomized phase-II study of Xeloda (capecitabine) and paclitaxel in patients with breast cancer progressing after anthracycline antibiotics]V M Moiseenko, S M O'Reilly, D C Dalbot, et al.
British Journal of Cancer|June 1, 1995
Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanomaW H Kruit, S H Goey, F Calabresi, et al.
Transplantation|August 1, 1983
Immunologic reactivity in marrow graft recipients receiving cyclosporine to prevent graft-versus-host diseaseV E Von Fliedner, M Jeannet, A Gratwohl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancerM Mackean, A Planting, C Twelves, et al.
Thymus|January 1, 1987
A comparison between ALG and bone marrow transplantation in treatment of severe aplastic anemiaB Speck, A Gratwohl, C Nissen, et al.
British Journal of Cancer|December 1, 1996
Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancerS H Goey, J W Gratama, J N Primrose, et al.
Experimental Hematology|February 1, 1986
Treatment of severe aplastic anemiaB Speck, A Gratwohl, C Nissen, et al.
Schweizerische Medizinische Wochenschrift|November 8, 1986
[Adverse effects of total body irradiation for bone marrow transplantation: prevention and therapy. Experience at Basel, July 1979-March 1986]A Tichelli, A Gratwohl, B Speck, et al.
British Journal of Cancer|July 7, 2000
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumoursL C Pronk, P Vasey, A Sparreboom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patientsB Reigner, J Verweij, L Dirix, et al.
Pageof 7